PIWA
OGN icon

Prevail Innovative Wealth Advisors’s Organon & Co OGN Stock Holding History

Prevail Innovative Wealth Advisors’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-30,262
Closed -$451K – 215
2025
Q1 		$451K Buy
+30,262
New +$465K 0.12% 146
2024
Q2 		– Sell
-72,656
Closed -$1.37M – 175
2024
Q1 		$1.37M Sell
72,656
-158,719
-69% -$2.72M 0.51% 79
2023
Q4 		$3.34M Buy
+231,375
New +$3.15M 1.59% 12

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Prevail Innovative Wealth Advisors's OGN Position: Q2 2025 in Review

Prevail Innovative Wealth Advisors sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 30,262 shares — an estimated $451K sold.

Prevail Innovative Wealth Advisors first reported a position in OGN in Q4 2023 and held it in 3 quarters. The position peaked at $3.34M in Q4 2023. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

  • Prevail Innovative Wealth Advisors reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
  • Prevail Innovative Wealth Advisors sold 30,262 Organon & Co shares in Q2 2025, an estimated $451K.
  • Prevail Innovative Wealth Advisors first reported a position in Organon & Co in Q4 2023 and held it in 3 quarters.
  • Prevail Innovative Wealth Advisors's Organon & Co position peaked at $3.34M in Q4 2023.
  • 695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Prevail Innovative Wealth Advisors's 13F filing for Q2 2025, filed 15 Aug 2025.